Our Company
Making The World a Healthier Place
At Balchem, we’re committed to finding innovative solutions to some of the most complex problems facing the nutrition, health, and food markets. Balchem Human Nutrition & Health delivers customized ingredient systems and key minerals and nutrients for the food, supplement and pharmaceutical markets. Balchem Animal Nutrition & Health is a global leader in choline production, nutrient encapsulation, chelated minerals, and functional ingredients. Balchem Specialty Products provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Balchem Today
Balchem employs approximately 1,300 people worldwide who are engaged in diverse activities, committed to developing the company into global market leadership positions. We provide the service, quality, and technology that enables our customers to win with their customers.
Our corporate headquarters is located in Montvale, New Jersey, and we have a broad network of sales offices, manufacturing sites, and R&D centers, primarily located in the US and Europe.
Human Nutrition & Health
Our Human Nutrition & Health business leverages decades of expertise in market insights, proven science, and product development to create winning solutions in health, wellbeing, and nutrition.
Animal Nutrition & Health
As a global leader of choline production and encapsulation technology, Balchem Animal Nutrition & Health provides a portfolio of nutrition products for ruminants, monogastrics, and companion animals.
Specialty Products
Performance Gases specializes in the packaging and global distribution of select gases. Plant Nutrition provides Metalosate® chelated minerals to the agricultural market worldwide.
Our History
Balchem was founded in 1967 by a group consisting of entrepreneurs, investors, and Dr. Leslie Balassa, an expert in the field of encapsulation. The company was initially housed in a laboratory on the top floor of the Chemists Club in New York City until purchasing its first manufacturing site, a former dairy in Slate Hill, New York. Balchem became a publicly traded company in 1970 and is listed on NASDAQ under the symbol “BCPC.”
Balchem has grown by developing unique technologies, by identifying novel applications for our science, and by acquiring new synergistic technologies and capabilities. All growth strategies are centered around our vision of making the world a healthier place.
